| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 421.17B | 633.67B | 421.67B | 370.68B | 417.62B | 462.82B |
| Gross Profit | 13.25B | 24.20B | 14.50B | 13.61B | 15.96B | 14.21B |
| EBITDA | 8.94B | 19.05B | 10.40B | 10.05B | 12.59B | 10.78B |
| Net Income | 5.32B | 10.02B | 5.59B | 2.10B | 4.91B | 6.38B |
Balance Sheet | ||||||
| Total Assets | 158.74B | 344.96B | 114.01B | 130.24B | 107.33B | 117.07B |
| Cash, Cash Equivalents and Short-Term Investments | 6.10B | 7.83B | 13.17B | 20.86B | 12.14B | 8.22B |
| Total Debt | 48.77B | 118.57B | 14.20B | 29.75B | 20.73B | 9.50B |
| Total Liabilities | 110.76B | 285.72B | 64.39B | 84.73B | 63.13B | 77.70B |
| Stockholders Equity | 47.98B | 59.24B | 49.62B | 45.51B | 43.21B | 38.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -97.56B | 9.20B | 4.41B | -5.17B | 5.75B |
| Operating Cash Flow | 0.00 | -97.47B | 9.21B | 4.42B | -4.96B | 5.90B |
| Investing Cash Flow | 0.00 | -362.00M | -21.00M | 494.00M | -263.00M | -183.00M |
| Financing Cash Flow | 0.00 | 95.97B | -16.85B | 2.90B | 8.58B | -7.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥101.36B | 6.87 | ― | 1.72% | 47.42% | 80.08% | |
71 Outperform | ¥161.53B | 10.73 | ― | 0.93% | 29.57% | -1.92% | |
70 Outperform | ¥72.85B | 15.74 | 5.37% | 3.41% | -4.59% | 25.08% | |
64 Neutral | ¥462.40B | 14.59 | ― | 2.87% | 12.90% | -40.53% | |
63 Neutral | ¥93.06B | 17.02 | ― | 1.85% | 12.50% | -4.02% | |
62 Neutral | ¥102.49B | 7.90 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |